Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1215 Views
-
Last post by frodo
-
- 0 Replies
- 888 Views
-
Last post by frodo
-
- 0 Replies
- 2092 Views
-
Last post by NHE
-
- 0 Replies
- 1190 Views
-
Last post by frodo
-
- 0 Replies
- 1093 Views
-
Last post by frodo
-
- 0 Replies
- 1110 Views
-
Last post by frodo
-
- 0 Replies
- 1297 Views
-
Last post by NHE
-
- 1 Replies
- 2700 Views
-
Last post by Tif
-
- 2 Replies
- 744 Views
-
Last post by DIM